Skip to main content

Table 7 Primary local medical treatment of interstitial pregnancy

From: Elective uterine artery embolization prior to laparoscopic resection of interstitial pregnancy: two cases and literature review

Author

N

Initial β-hCG

Local medical treatment

Hospital stay

Negative β-hCG

Complications

Success

Timor-Tritsch et al. [82]

1*

14,100

KCL 0.5 ml of 2 mEq/ml cornual

N/A

6 (*)

Miscarriage

1/1

1

1400

MTX 25 mg cornual

4

5

–

1/1

Benifla et al. [27]

2

16,000–43,000

MTX 1 mg/kg intrasaccular, UG1

3 (1/2)

6 (1/2)

Bleeding 1/2

1/2

 

6

360–10,000

MTX 1 mg/kg intrasaccular, UG/LG

3

1–3

–

6/6

 

3*

15,000–25,205

KCL 2 mEq in 2 ml volume intrasaccular

3

*

Miscarriage 2/3

3/3

Baker et al. [83]

1*

18,423

MTX 12.5 mg with 1 ml of 20% KCL

0

*

–

1/1

Wilkinson et al. [84]

1

10,500

MTX 40 mg

N/A

N/A

–

1/1

Lin et al. [85]

1

3256

MTX 50 mg with diluted vasopressin

2

2

–

1/1

Oyawoye et al. [86]

1*

78,685

MTX

N/A

*

–

1/1

Verity et al. [59]

1

5780

MTX 50 mg, LG2

N/A

9

–

1/1

 

1

5578

MTX 50 mg, LG

N/A

4

–

1/1

Tulandi et al. [39]

2

2627–6739

MTX, LG

N/A

7 (1/2)

–

1/2

2

 

MTX

N/A

7

–

2/2

Cassik et al. [28]

23

102–69,820

MTX 25 mg, UG3

N/A

3–14

–

21/23

Chou et al. [87]

1

6413

KCL 2.5 mEq, UG

N/A

12

–

1/1

Narang and Kalu [88]

2

3700–40,000

MTX 50 mg/m2

N/A

N/A

–

2/2

Andrés et al. [89]

3

6193–21,999

MTX 50 mg intrasaccular, UG4

1

4–10

Leukopenia 1/3

2/3

Monia et al. [71]

2

7909–64,000

MTX 20–40 mg5

N/A

2

–

2/2

 

1

8400

MTX 60 mg

N/A

4

–

1/1

Surbone et al. [74]

6

2974–15,022

MTX 1 mg/kg

N/A

N/A

–

5/6

Swank et al. [90]

1

90,504

MTX 50 mg5

7

7

–

1/1

Douysset et al. [46]

2

369–45,780

N/A

N/A

N/A

–

2/2

Framarino et al. [29]

14

2800–3200

MTX 25 mg

N/A

Max. 8

–

14/14

Yu et al. [91]

4*

N/A

MTX 1 mg/kg

N/A

N/A

–

4/4

Maçães et al. [92]

1

2776

MTX 25 mg with 2 mEq KCL

N/A

8

–

1/1

Leggieri et al. [93]

1

5055

MTX 25 mg

4

3

–

1/1

Nikodijevic et al. [48]

3

19,563

MTX5

N/A

4

–

2/2

 

1

 

MTX

N/A

N/A

N/A

0/1

Kim et al. [12]

2

2292–59,090

MTX 1 mg/kg

N/A

N/A

N/A

7/8

 

6

 

MTX 1 mg/kg5

N/A

N/A

N/A

 
  1. N number of cases, β-hCG mIU/ml, KCL potassium chloride, MTX methotrexate, UG under ultrasound guidance, LG under laparoscopic guidance, hospital stay days, negative β-hCG weeks
  2. *Heterotopic pregnancy: 1: MTX 1 mg/kg/d IM 3 days after, 2: MTX 50 mg IM on days 2 and 4, 3: in viable pregnancies + KCL intracardially (5/23), 4 MTX 50 mg/m2IM (2/3 patients), 5: systemic MTX